Future Market Insights (FMI), a leading provider of market research and consulting services, anticipates substantial growth in the global anatomic pathology market. Valued at USD 32.5 million in 2022, the market is poised to expand at a robust CAGR of 8.2% from 2022 to 2030, reaching USD 61.1 million by the end of the decade.
Anatomic pathology plays a pivotal role in disease diagnosis and is integral to advancements in drug discovery and development. FMI, renowned for its innovative methodologies, is uniquely positioned to capitalize on this growth trajectory. Leveraging cutting-edge technology and a steadfast commitment to excellence, FMI continues to lead in this dynamic industry.
Request For A Sample: https://www.futuremarketinsights.com/reports/sample/rep-gb-12370
“We are excited about the immense potential of the global anatomic pathology market,” remarked a FMI. “Our strategic insights and innovative approach enable us to navigate and drive growth in this evolving landscape.”
Key Findings from the Future Market Insights Report:
- The anatomic pathology market is experiencing significant growth due to its expanding role in disease diagnosis.
- The market is also being driven by the crucial role anatomic pathology plays in drug discovery and development.
- Future Market Insights is well-positioned to capitalize on this growth with its commitment to cutting-edge research and industry expertise.
Key Takeaways: Anatomic Pathology Market Poised for Growth
- The global anatomic pathology market is expected to see significant growth, reaching USD 61.1 million by 2030 at a CAGR of 8.2%.
- The U.S. is projected to be a major player due to factors like rising cancer rates, high research funding, favorable reimbursement policies, and a strong presence of industry leaders.
- High investment in R&D for personalized medicine and chronic disease management strengthens the U.S. market position.
- An increase in chronic diseases and adoption of advanced pathology devices will drive Germany’s market growth.
- The European market, led by Germany and the U.K., is expected to hold a substantial share (25.7%) of the global market.
Key Participant Insights:
The key market players are focusing on technological upgradations and expansion strategies to keep themselves fiercely competitive.
For instance:
- In Jul 2020, Bio SB tabled its Fast Mohs PolyDetector Plus Detection System, which comes across as a super sensitive nonbiotin monovalent Fab micropolymer immunohistochemistry system to detect IVD antibodies for squamous cell carcinoma, basal cell carcinoma, and melanoma.
- In Jan 2019, Quest Diagnostics announced completion of acquisition of the US laboratory services business that belonged to Oxford Immunotec (the T-Spot and Accutix tick-borne disease testing services, since then, are part of Quest’s infectious disease testing services.
- In 2018, Leica Microsystems entered into a collaboration with Thermo Fisher to develop an integrated cryotomography workflow with regards to research.
Ask for Customize Research Report: https://www.futuremarketinsights.com/customization-available/rep-gb-12370
Key companies profiled:
- Laboratory Corporation of America Holdings
- Sakura Finetek USA, Inc.
- F.Hoffmann-La Roche AG
- Cardinal Health, Inc.
- BioGenex
- NeoGenomics
- Agilent Technologies
The US continues to be one of the leading markets for anatomic pathology industry globally. Strong presence of some of the leading players, combined with relatively easier funding for R&D will drive the US anatomic pathology industry during the assessment period.
The Europe anatomic pathology industry is also likely to grow at a brisk pace during the assessment period. The growth will remain concentrated in Western Europe, as has been the case traditionally.
Asia Pacific represents a high growth market for anatomic pathology stakeholders. Many countries in the region are renewing their focus on healthcare, as the current Covid-19 crisis has reinforced the necessity of a robust healthcare system.
Get Complete Full Report: https://www.futuremarketinsights.com/checkout/12370
Key Segments of Anatomic Pathology Industry Survey:
Anatomic Pathology Industry by Product & Service:
- Anatomic Pathology Instruments
- Anatomic Pathology Consumables
- Anatomic Pathology Services
Anatomic Pathology Industry by Application:
- Disease Diagnosis
- Drug Discovery and Development
- Others
Anatomic Pathology Industry by End User:
- Hospitals
- Research Laboratories
- Diagnostic Laboratories
- Others
Anatomic Pathology Industry by Region:
- North America Anatomic Pathology Industry
- Latin America Anatomic Pathology Industry
- Europe Anatomic Pathology Industry
- East Asia Anatomic Pathology Industry
- South Asia & Pacific Anatomic Pathology Industry
- Middle East & Africa (MEA) Anatomic Pathology Industry
About Future Market Insights (FMI)
Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 400 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.
Contact Us:
Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-845-579-5705
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube
